# Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients

> **NCT01089868** · — · COMPLETED · sponsor: **Ludwig-Maximilians - University of Munich** · enrollment: 79 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01089868
- **Lead sponsor:** Ludwig-Maximilians - University of Munich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2011-06
- **Final completion:** 2012-07
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2012-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01089868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01089868, "Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01089868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*